| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/08/2001 | WO2001015700A1 POLYMORPHS OF N-METHYL-N-(3-{3-[2-THIENYLCARBONYL]-PYRAZOL-[1,5-α]-PYRIMIDIN -7-YL }PHENYL )ACETAMIDE AND COMPOSITIONS AND METHODS RELATED THERETO |
| 03/08/2001 | WO2001015699A1 Injectable buprenorphine microparticle compositions and their use |
| 03/08/2001 | WO2001015696A1 Use of nicotine or derivatives thereof in a medicine for treating neurological diseases, in particular parkinson disease |
| 03/08/2001 | WO2001015693A2 Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof |
| 03/08/2001 | WO2001015685A1 Novel uses of sigma receptor agonists |
| 03/08/2001 | WO2001015683A1 Delayed-action form of administration containing tramadol saccharinate |
| 03/08/2001 | WO2001015682A1 Pharmaceutical tramadol salts |
| 03/08/2001 | WO2001015681A1 Oral pharmaceutical forms of administration with a delayed action |
| 03/08/2001 | WO2001015668A1 Controlled release pellet formulation |
| 03/08/2001 | WO2001015667A1 Oral dosage forms |
| 03/08/2001 | WO2001015664A2 Coformulation methods and their products |
| 03/08/2001 | WO2001015554A1 Metal-containing compositions, preparations and uses |
| 03/08/2001 | WO2001015553A1 Dietary food supplement containing natural cyclooxygenase inhibitors |
| 03/08/2001 | WO2000078751A3 Compounds for use in treatment of neurological disorders |
| 03/08/2001 | WO2000077184A9 Caspase-8 crystals, models and methods |
| 03/08/2001 | WO2000073501A3 Nucleic acid molecules with specific identification of native prpsc, their production and the use thereof |
| 03/08/2001 | WO2000066735A3 Human ion channel proteins |
| 03/08/2001 | WO2000063169A3 N-dimethyl amino ethanol carboxylate pyrrolidone hydrate in its crystallised form |
| 03/08/2001 | WO2000059448A3 Association of no-synthase inhibitor(s) and metabolic antioxidant(s) |
| 03/08/2001 | WO2000050872A3 A system for cell-based screening |
| 03/08/2001 | WO2000049137A3 Pluripotential cell derived from an embryonic stem cell and a nucleus of a somatic cell |
| 03/08/2001 | WO2000020447A8 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses |
| 03/08/2001 | WO1999065449A8 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB |
| 03/08/2001 | WO1999063930A8 Novel angiotensin receptor modulators and their uses |
| 03/08/2001 | DE19937537A1 Substituierte 2-Dialkylaminoalkylbiphenyl-Derivate 2-substituted derivatives Dialkylaminoalkylbiphenyl |
| 03/08/2001 | CA2417639A1 Isolation of natural l-.beta.-3-indolylalanine and enrichment of natural aliphatic amino acid mixtures with natural l-.beta.-3-indolylalanine |
| 03/08/2001 | CA2403243A1 Nucleic acid based modulators of gene expression |
| 03/08/2001 | CA2388560A1 Sustained-release form of administration containing tramadol saccharinate |
| 03/08/2001 | CA2388036A1 Novel uses of sigma receptor agonists |
| 03/08/2001 | CA2387291A1 Dna encoding the human serine protease t |
| 03/08/2001 | CA2384126A1 Reverse-turn mimetics and methods relating thereto |
| 03/08/2001 | CA2384055A1 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | CA2384026A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 03/08/2001 | CA2383381A1 Methods and compositions relating to body weight and eating disorders |
| 03/08/2001 | CA2383307A1 Arylalkyloxyalkylamines and arylalkylthioalkylamines, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors |
| 03/08/2001 | CA2383002A1 Substituted .alpha.-hydroxy acid caspase inhibitors and the use thereof |
| 03/08/2001 | CA2382966A1 Biaryl-oxa(thia)zole derivatives and their use as ppars modulators |
| 03/08/2001 | CA2382961A1 Zymogen activation system |
| 03/08/2001 | CA2382953A1 Dna encoding the human serine protease c-e |
| 03/08/2001 | CA2382789A1 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 03/08/2001 | CA2382556A1 Coformulation methods and their products |
| 03/08/2001 | CA2382449A1 Metal-containing compositions, preparations and uses |
| 03/08/2001 | CA2381553A1 Fused pyrrolecarboxamides: gaba brain receptor ligands |
| 03/08/2001 | CA2381451A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 03/08/2001 | CA2380760A1 New interferon beta-like molecules |
| 03/08/2001 | CA2379421A1 Sulfonylphenylpyrazole compounds useful as cox-2 inhibitors |
| 03/07/2001 | EP1081147A2 Substituted nortropanes and their use as imaging agents for neurodegenerative disorders |
| 03/07/2001 | EP1081142A2 Novel N-Aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands |
| 03/07/2001 | EP1081137A1 Selective inhibitors of aggrecanase in osteoarthritis treatment |
| 03/07/2001 | EP1080370A1 Identification of broadly reactive dr restricted epitopes |
| 03/07/2001 | EP1080215A1 Mutant herpes simplex viruses and uses thereof |
| 03/07/2001 | EP1080202A2 Convection-enhanced delivery of aav vectors |
| 03/07/2001 | EP1080194A2 Human transmembrane proteins |
| 03/07/2001 | EP1080190A1 Calmodulin related protein |
| 03/07/2001 | EP1080185A2 Myelin basic protein peptides and uses thereof |
| 03/07/2001 | EP1080180A2 Secreted proteins and polynucleotides encoding them |
| 03/07/2001 | EP1080110A2 Use of activated t cells, nervous system-specific antigens for treating disorders of the nevrous system |
| 03/07/2001 | EP1080095A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 03/07/2001 | EP1080091A1 Novel 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes |
| 03/07/2001 | EP1080087A1 Novel 2-alkyl substituted imidazole compounds |
| 03/07/2001 | EP1080083A1 Novel heterocyclically substituted amides with cysteine protease-inhibiting effect |
| 03/07/2001 | EP1080080A1 Novel therapeutic agents that modulate neurokinin receptors |
| 03/07/2001 | EP1080078A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders |
| 03/07/2001 | EP1080074A1 New heterocyclically substituted amides, their production and their use |
| 03/07/2001 | EP1080068A1 Modulators of protein tyrosine phosphatases |
| 03/07/2001 | EP1079860A1 Nicotine immunogen |
| 03/07/2001 | EP1079844A1 Chaperone suppression of ataxin-1 aggregation and altered subcellular proteasome localization imply protein misfolding in sca1 |
| 03/07/2001 | EP1079833A1 Cocaine receptor binding ligands |
| 03/07/2001 | EP1079828A1 New use |
| 03/07/2001 | EP1079826A2 Use of indigoid bisindole derivatives for the manufacture of a medicament to inhibit cyclin dependent kinases |
| 03/07/2001 | EP1079825A2 Compounds that inhibit the binding of integrins to their receptors |
| 03/07/2001 | EP1079804A1 Pharmaceutical compositions comprising an amphoteric surfactant an alkoxylated cetyl alcohol and a polar drug |
| 03/07/2001 | EP1079763A2 Serotonergic 5ht 7? receptor compounds for treating ocular and cns disorders |
| 03/07/2001 | EP0840732B1 Substituted benzolactam compounds as substance p antagonists |
| 03/07/2001 | EP0783505B1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE |
| 03/07/2001 | EP0777650B1 Biphenylamide derivatives as 5ht 1d antagonists |
| 03/07/2001 | EP0734379B1 2-arylalkenyl-azacycloalkane derivatives as sigma receptor ligands, preparation method therefor and therapeutical use thereof |
| 03/07/2001 | EP0625969B1 Arylalkoxyphenoxy-imidazoline compounds |
| 03/07/2001 | CN1286688A Method for preparation of citalopram |
| 03/07/2001 | CN1286687A Method for preparation of citalopram |
| 03/07/2001 | CN1286632A Use of purine nucleosides for modulating axonal outgrowth of central nervous system neurons |
| 03/07/2001 | CN1286255A Pyridine compounds, their preparation method and pharmaceutical compositions contg them |
| 03/07/2001 | CN1286116A Medicine for treating cerebral infarction and its preparing process |
| 03/07/2001 | CN1286113A Medical capsule for treating rheumatism and building up body and its preparing process |
| 03/07/2001 | CN1062908C Polypeptides and DNAs encoding them |
| 03/06/2001 | US6197982 Vitamin D analogues |
| 03/06/2001 | US6197958 Carboxylic acid derivatives, their preparation and use |
| 03/06/2001 | US6197828 Derivatives of (+)-venlafaxine and methods of preparing and using the same |
| 03/06/2001 | US6197827 Nicotine receptor antagonists and either an anti-depressant or an anti-anxiety drug, mecamylamine and bupropion |
| 03/06/2001 | US6197824 Benzamidine derivatives and the use thereof as medicaments with LTB4-antagonistic effect |
| 03/06/2001 | US6197822 Neuropeptide antagonists |
| 03/06/2001 | US6197810 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides |
| 03/06/2001 | US6197794 Antiinflamamtory agents; immunology diseases |
| 03/06/2001 | US6197785 Cardiovascular disorders |
| 03/06/2001 | US6197782 Therapy for sexual disorders |
| 03/06/2001 | US6197778 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 03/06/2001 | US6197773 N-acyl and N-aroyl aralkyl amides as serotonergic agents |
| 03/06/2001 | US6197769 Serotonine receptors antagonist; gastrointestinal disorders, antiarrhythmia agents; incontinence |
| 03/06/2001 | US6197764 Clozapine compositions and uses thereof |
| 03/06/2001 | US6197760 Isophosphoramide mustard analogs and use thereof |